x

Posted 11 July, 2023

Innoviva, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:INVA in a 8-K filed on 11 July, 2023.


  On July 10, 2023, Deborah L. Birx, a member of the Board of Directors of Innoviva, Inc. (the "Board") and chair of the Audit Committee, resigned from the Board, including the committees of the Board of which she is a member, effective as of July 10, 2023, AND ACCEPTED the position of Chief Executive Officer of Armata Pharmaceuticals, Inc., a company in which Innoviva holds a majority ownership interest.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Innoviva, Inc.
Health Care/Life Sciences • Pharmaceuticals
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Market Cap
$965M
View Company Details
Innoviva, Inc. by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On July 10, 2023, Deborah L. Birx, a member of the Board of Directors of Innoviva, Inc. (the "Board") and chair of the Audit Committee, resigned from the Board, including the committees of the Board of which she is a member, effective as of July 10, 2023, AND ACCEPTED the position of Chief Executive Officer of Armata Pharmaceuticals, Inc., a company in which Innoviva holds a majority ownership interest. Dr. Birx's decision to resign was not the result of any disagreement with the Company on any matter relating to how the Company has operated, its policies or its practices, including its controls or financial related matters.